Rourke BJ, Singh P, Lessard S, Chen T, Oliver D, Konnaris M, et al
Most compounded clinics either charge extra for these or do not offer them at all
The study findings revealed a 30% increase in mortality following DXN treatment, whereas the combination of DXN and TIR resulted in a 40% mortality rate after 10 days in the animal subjects, with the control and TIR groups showing no mortality
Patients interested in similar treatments should discuss currently approved alternatives with their healthcare providers.
Anyone handling retatrutide whether as a clinical trial participant or healthcare professional must follow the Investigational Medicinal Product (IMP) label, the trial manual, or the dispensing pharmacist's instructions, and must not use the product beyond its labelled expiry date
I decided to run it